Thirty Years of Saying NO: Sources, Fate, Actions, and Misfortunes of the Endothelium-Derived Vasodilator Mediator

Circulation Research

Volumn 119, Issue 2, 2016, Pages 375-396

  Vanhoutte, Paul M ^a,b   Zhao, Yingzi ^a,b   Xu, Aimin ^a,b   Leung, Susan W S ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

atherosclerosis; calcium; endothelium; nitric oxide; reactive oxygen species

Indexed keywords

CALCIUM; ESTROGEN; HORMONE; MEMBRANE RECEPTOR; NITRIC OXIDE SYNTHASE; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; NITRIC OXIDE;

CHRONIC STRESS; DIMERIZATION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SEX; SHEAR STRESS; SIGNAL TRANSDUCTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS); VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; VASODILATION; VASODILATOR AGENTS;

EID: 84978062956     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.306531     Document Type: Review

References (189)

1. Furchgott RF, Zawadzki JV, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 373 376
2. Furchgott RF, Vanhoutte PM, Studies on relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid activatable factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. Vasodilatation: Vascular Smooth Muscle Peptides, Autonomic Nerves, and Endothelium 1988 New York Raven Press 401 414. In
3. Furchgott RF, Vanhoutte PM, Endothelium-derived relaxing and contracting factors. FASEB J 1989 3 2007 2018
4. Ignarro LJ, Byrns RE, Wood KS, Vanhoutte PM, Biochemical and pharmacological properties of endothelium-derived relaxing factor and its similarity to nitric oxide radical. Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves and Endothelium 1988 New York Raven Press 427 436. In
5. Lüscher TF, Vanhoutte PM, The Endothelium: Modulator of Cardiovascular Function 1990 Boca Raton: CRC Press 1 228
6. Moncada S, Nitric oxide in the vasculature: physiology and pathophysiology. Ann N Y Acad Sci 1997 811 60 67; discussion 67
7. Murad V, Discovery of some of the biological effects of nitric oxide and its role in cell signaling (nobel lecture). Angew Chem Int Edit 1999 38 1857 1868
8. Vanhoutte PM, How we learned to say NO. Arterioscler Thromb Vasc Biol 2009 29 1156 1160. doi: 10.1161/ATVBAHA.109.190215
9. Loscalzo J, The identification of nitric oxide as endothelium-derived relaxing factor. Circ Res 2013 113 100 103. doi: 10.1161/CIRCRESAHA.113.301577
10. Ignarro LJ, Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 1990 30 535 560. doi: 10.1146/annurev.pa.30.040190.002535
11. Cooke JP, The pivotal role of nitric oxide for vascular health. Can J Cardiol 2004 20 7b 15b
12. Félétou M, Vanhoutte PM, Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol 2006 291 H985 1002. doi: 10.1152/ajpheart.00292.2006
13. Vanhoutte PM, Endothelial dysfunction-the first step toward coronary arteriosclerosis. Circ J 2009 73 595 601
14. Vanhoutte PM, Shimokawa H, Tang EH, Feletou M, Endothelial dysfunction and vascular disease. Acta Physiol (Oxf) 2009 196 193 222. doi: 10.1111/j.1748-1716.2009.01964.x
15. Vanhoutte PM, Shimokawa H, Feletou M, Tang EHC, Endothelial dysfunction and vascular disease-a thirthieth anniversary update [published online ahead of print December 26, 2015]. Acta Physiol. doi: 10.1111/apha.12646. http://onlinelibrary.wiley.com/doi/10.1111/apha.12646/abstract;jsessionid=E649F7D3BD96862964C37BCAD1CD6CBF.f02t03
16. Busse R, Edwards G, Félétou M, Fleming I, Vanhoutte PM, Weston AH, EDHF: bringing the concepts together. Trends Pharmacol Sci 2002 23 374 380
17. Félétou M, Vanhoutte PM, EDHF: an update. Clin Sci (Lond) 2009 117 139 155. doi: 10.1042/CS20090096
18. Cohen RA, Félétou M, Vanhoutte PM, Verbeuren TJ, TP receptors and oxidative stress hand in hand from endothelial dysfunction to atherosclerosis. Adv Pharmacol 2010 60 85 106
19. Vanhoutte PM, Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension 2011 57 526 531. doi: 10.1161/HYPERTENSIONAHA.110.165100
20. Félétou M, Huang Y, Vanhoutte PM, Endothelium-mediated control of vascular tone: COX-1 and COX-2 products. Br J Pharmacol 2011 164 894 912. doi: 10.1111/j.1476-5381.2011.01276.x
21. De Mey JG, Vanhoutte PM, End o' the line revisited: moving on from nitric oxide to CGRP. Life Sci 2014 118 120 128. doi: 10.1016/j.lfs.2014.04.012
22. Leung SW, Vanhoutte PM, Endothelium-dependent hyperpolarization: Age, gender and high blood pressure, do they matter [published online ahead of print December 1, 2015]? Acta Physiol. doi: 10.1111/apha.12628. http://onlinelibrary.wiley.com/doi/10.1111/apha.12628/abstract
23. Alderton WK, Cooper CE, Knowles RG, Nitric oxide synthases: structure, function and inhibition. Biochem J 2001 357 593 615
24. Förstermann U, Münzel T, Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 2006 113 1708 1714. doi: 10.1161/CIRCULATIONAHA.105.602532
25. Förstermann U, Sessa WC, Nitric oxide synthases: regulation and function. Eur Heart J 2012 33 829 37, 837a. doi: 10.1093/eurheartj/ehr304
26. Dessy C, Feron O, Balligand JL, The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and shared by the 'endothelium-derived hyperpolarizing factor'. Pflugers Arch 2010 459 817 827. doi: 10.1007/s00424-010-0815-3
27. Fleming I, Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 2010 459 793 806. doi: 10.1007/s00424-009-0767-7
28. Michel T, Vanhoutte PM, Cellular signaling and NO production. Pflugers Arch 2010 459 807 816. doi: 10.1007/s00424-009-0765-9
29. Zhao YZ, Vanhoutte PM, Leung SWS, Vascular nitric oxide: Beyond eNOS. J Pharmacol Sci 2015 129 83 94
30. Bryan NS, Bian K, Murad F, Discovery of the nitric oxide signaling pathway and targets for drug development. Front Biosci (Landmark Ed) 2009 14 1 18
31. d'Uscio LV, eNOS uncoupling in pulmonary hypertension. Cardiovasc Res 2011 92 359 360. doi: 10.1093/cvr/cvr270
32. Maron BA, Michel T, Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase. Circ J 2012 76 2497 2512
33. Cai Z, Lu Q, Ding Y, Wang Q, Xiao L, Song P, Zou MH, Endothelial nitric oxide synthase-derived nitric oxide prevents dihydrofolate reductase degradation via promoting S-nitrosylation. Arterioscler Thromb Vasc Biol 2015 35 2366 2373. doi: 10.1161/ATVBAHA.115.305796
34. Flavahan NA, Vanhoutte PM, Endothelial cell signaling and endothelial dysfunction. Am J Hypertens 1995 8 28S 41S
35. Boulanger CM, Vanhoutte PM, G proteins and endothelium-dependent relaxations. J Vasc Res 1997 34 175 185
36. Vanhoutte PM, Regenerated endothelium and its senescent response to aggregating platelets. Circ J 2016 80 783 790. doi: 10.1253/circj.CJ-16-0179
37. Adams DJ, Barakeh J, Laskey R, Van Breemen C, Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989 3 2389 2400
38. Marletta MA, Nitric oxide: biosynthesis and biological significance. Trends Biochem Sci 1989 14 488 492
39. Tran QK, Ohashi K, Watanabe H, Calcium signalling in endothelial cells. Cardiovasc Res 2000 48 13 22
40. Nilius B, Droogmans G, Ion channels and their functional role in vascular endothelium. Physiol Rev 2001 81 1415 1459
41. Zhang AY, Li PL, Vascular physiology of a Ca2+ mobilizing second messenger-cyclic ADP-ribose. J Cell Mol Med 2006 10 407 422
42. Zhou C, Wu S, T-type calcium channels in pulmonary vascular endothelium. Microcirculation 2006 13 645 656. doi: 10.1080/10739680600930289
43. Folgering JH, Sharif-Naeini R, Dedman A, Patel A, Delmas P, Honoré E, Molecular basis of the mammalian pressure-sensitive ion channels: focus on vascular mechanotransduction. Prog Biophys Mol Biol 2008 97 180 195. doi: 10.1016/j.pbiomolbio.2008.02.006
44. Filosa JA, Yao X, Rath G, TRPV4 and the regulation of vascular tone. J Cardiovasc Pharmacol 2013 61 113 119. doi: 10.1097/FJC.0b013e318279ba42
45. Scheitlin CG, Julian JA, Shanmughapriya S, Madesh M, Tsoukias NM, Alevriadou BR, Endothelial mitochondria regulate the intracellular Ca2+ response to fluid shear stress. Am J Physiol Cell Physiol 2016 310 C479 C490. doi: 10.1152/ajpcell.00171.2015
46. Rohde D, Ritterhoff J, Voelkers M, Katus HA, Parker TG, Most P, S100A1: a multifaceted therapeutic target in cardiovascular disease. J Cardiovasc Transl Res 2010 3 525 537. doi: 10.1007/s12265-010-9211-9
47. Prendergast C, Quayle J, Burdyga T, Wray S, Atherosclerosis affects calcium signalling in endothelial cells from apolipoprotein E knockout mice before plaque formation. Cell Calcium 2014 55 146 154. doi: 10.1016/j.ceca.2014.02.012
48. Francis M, Waldrup JR, Qian X, Solodushko V, Meriwether J, Taylor MS, Functional tuning of intrinsic endothelial Ca2+ dynamics in swine coronary arteries. Circ Res 2016 118 1078 1090. doi: 10.1161/CIRCRESAHA.115.308141
49. Pires PW, Earley S, No static at all: tuning into the complexities of Ca2+ signaling in the endothelium. Circ Res 2016 118 1042 1044. doi: 10.1161/CIRCRESAHA.116.308519
50. Dudzinski DM, Igarashi J, Greif D, Michel T, The regulation and pharmacology of endothelial nitric oxide synthase. Annu Rev Pharmacol Toxicol 2006 46 235 276. doi: 10.1146/annurev.pharmtox.44.101802.121844
51. Heiss EH, Dirsch VM, Regulation of eNOS enzyme activity by posttranslational modification. Curr Pharm Des 2014 20 3503 3513
52. Han F, Zhang S, Hou N, Wang D, Sun X, Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. Am J Physiol Heart Circ Physiol 2015 309 H1501 H1508. doi: 10.1152/ajpheart.00443.2015
53. Rodriguez J, Maloney RE, Rassaf T, Bryan NS, Feelisch M, Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci USA 2003 100 336 341. doi: 10.1073/pnas.0234600100
54. Chen K, Pittman RN, Popel AS, Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxid Redox Signal 2008 10 1185 1198. doi: 10.1089/ars.2007.1959
55. Zhao Y, Vanhoutte PM, Leung SW, Endothelial nitric oxide synthase-independent release of nitric oxide in the aorta of the spontaneously hypertensive rat. J Pharmacol Exp Ther 2013 344 15 22. doi: 10.1124/jpet.112.198721
56. Stamler JS, S-nitrosothiols in the blood: roles, amounts, and methods of analysis. Circ Res 2004 94 414 417. doi: 10.1161/01.RES.0000122071.55721.BC
57. Yang Y, Loscalzo J, S-nitrosoprotein formation and localization in endothelial cells. Proc Natl Acad Sci USA 2005 102 117 122
58. Daaka Y, S-nitrosylation-regulated gpcr signaling. Biochim Biophys Acta 2012 1820 743 751
59. Beckman JS, Koppenol WH, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996 271 C1424 C1437
60. Kelm M, Nitric oxide metabolism and breakdown. Biochim Biophys Acta 1999 1411 273 289
61. Gao Y, The multiple actions of NO. Pflugers Arch 2010 459 829 839. doi: 10.1007/s00424-009-0773-9
62. Nisoli E, Falcone S, Tonello C, Cozzi V, Palomba L, Fiorani M, Pisconti A, Brunelli S, Cardile A, Francolini M, Cantoni O, Carruba MO, Moncada S, Clementi E, Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA 2004 101 16507 16512. doi: 10.1073/pnas.0405432101
63. Borniquel S, Valle I, Cadenas S, Lamas S, Monsalve M, Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator PGC-1alpha. FASEB J 2006 20 1889 1891. doi: 10.1096/fj.05-5189fje
64. Miller MW, Knaub LA, Olivera-Fragoso LF, Keller AC, Balasubramaniam V, Watson PA, Reusch JE, Nitric oxide regulates vascular adaptive mitochondrial dynamics. Am J Physiol Heart Circ Physiol 2013 304 H1624 1633
65. Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C, Cohen RA, S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004 10 1200 1207. doi: 10.1038/nm1119
66. Carvajal JA, Germain AM, Huidobro-Toro JP, Weiner CP, Molecular mechanism of cGMP-mediated smooth muscle relaxation. J Cell Physiol 2000 184 409 420. doi: 10.1002/1097-4652(200009)184:3<409:AID-JCP16>3.0.CO;2-K
67. Derbyshire ER, Marletta MA, Structure and regulation of soluble guanylate cyclase. Annu Rev Biochem 2012 81 533 559. doi: 10.1146/annurev-biochem-050410-100030
68. Félétou M, Köhler R, Vanhoutte PM, Nitric oxide: orchestrator of endothelium-dependent responses. Ann Med 2012 44 694 716. doi: 10.3109/07853890.2011.585658
69. Shimokawa H, 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside. Eur Heart J 2014 35 3180 3193. doi: 10.1093/eurheartj/ehu427
70. Godo S, Sawada A, Saito H, Ikeda S, Enkhjargal B, Suzuki K, Tanaka S, Shimokawa H, Disruption of physiological balance between nitric oxide and endothelium-dependent hyperpolarization impairs cardiovascular homeostasis in mice. Arterioscler Thromb Vasc Biol 2016 36 97 107. doi: 10.1161/ATVBAHA.115.306499
71. Félétou M, Tang EHC, Vanhoutte PM, Nitric oxide the gatekeeper of endothelial vasomotor control. Front Biosci 2008 13 4198 4217
72. Vanhoutte PM, Say NO to ET. J Auton Nerv Syst 2000 81 271 277
73. Zellers TM, McCormick J, Wu Y, Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins. Am J Physiol 1994 267 H139 H147
74. Corcoran JJ, Nicholson C, Sweeney M, Charnock JC, Robson SC, Westwood M, Taggart MJ, Human uterine and placental arteries exhibit tissue-specific acute responses to 17β-estradiol and estrogen-receptor-specific agonists. Mol Hum Reprod 2014 20 433 441. doi: 10.1093/molehr/gat095
75. Izhar U, Hasdai D, Richardson DM, Cohen P, Lerman A, Insulin and insulin-like growth factor-I cause vasorelaxation in human vessels in vitro. Coron Artery Dis 2000 11 69 76
76. Katusic ZS, Shepherd JT, Vanhoutte PM, Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors. J Pharmacol Exp Ther 1986 236 166 170
77. De Mey JG, Vanhoutte PM, Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res 1982 51 439 447
78. Katusic ZS, Shepherd JT, Vanhoutte PM, Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circ Res 1984 55 575 579
79. Chan CK, Vanhoutte PM, Secretoneurin facilitates endothelium-dependent relaxations in porcine coronary arteries. Am J Physiol Heart Circ Physiol 2011 300 H1159 H1165. doi: 10.1152/ajpheart.00519.2010
80. Mombouli JV, Vanhoutte PM, Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol 1995 35 679 705. doi: 10.1146/annurev.pa.35.040195.003335
81. Davies PF, Flow-mediated endothelial mechanotransduction. Physiol Rev 1995 75 519 560
82. Liu HB, Zhang J, Xin SY, Liu C, Wang CY, Zhao D, Zhang ZR, Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function. J Cardiovasc Pharmacol 2013 61 461 470. doi: 10.1097/FJC.0b013e31828c0933
83. Chiu JJ, Chien S, Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 2011 91 327 387. doi: 10.1152/physrev.00047.2009
84. Davis ME, Cai H, Drummond GR, Harrison DG, Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 2001 89 1073 1080
85. Busse R, Fleming I, Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces. Trends Pharmacol Sci 2003 24 24 29
86. 11 control blood pressure by mediating endothelial mechanotransduction. J Clin Invest 2015 125 3077 3086. doi: 10.1172/JCI81067
87. Zou Q, Leung SW, Vanhoutte PM, Transient receptor potential channel opening releases endogenous acetylcholine, which contributes to endothelium-dependent relaxation induced by mild hypothermia in spontaneously hypertensive rat but not Wistar-Kyoto rat arteries. J Pharmacol Exp Ther 2015 354 121 130. doi: 10.1124/jpet.115.223693
88. Miller VM, Duckles SP, Vascular actions of estrogens: functional implications. Pharmacol Rev 2008 60 210 241
89. Li H, Liu Z, Gou Y, Yu H, Siminelakis S, Wang S, Kong D, Zhou Y, Liu Z, Ding Y, Yao D, Estradiol mediates vasculoprotection via ERRα-dependent regulation of lipid and ROS metabolism in the endothelium. J Mol Cell Cardiol 2015 87 92 101. doi: 10.1016/j.yjmcc.2015.08.008
90. Wang ZV, Scherer PE, Adiponectin, cardiovascular function, and hypertension. Hypertension 2008 51 8 14. doi: 10.1161/HYPERTENSIONAHA.107.099424
91. Zhu W, Cheng KK, Vanhoutte PM, Lam KS, Xu A, Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clin Sci (Lond) 2008 114 361 374. doi: 10.1042/CS20070347
92. Xu A, Vanhoutte PM, Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 2012 302 H1231 H1240. doi: 10.1152/ajpheart.00765.2011
93. Huby AC, Antonova G, Groenendyk J, Gomez-Sanchez CE, Bollag WB, Filosa JA, Belin de Chantemèle EJ, Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation 2015 132 2134 2145. doi: 10.1161/CIRCULATIONAHA.115.018226
94. Lopes RA, Neves KB, Tostes RC, Montezano AC, Touyz RM, Downregulation of nuclear factor erythroid 2-related factor and associated antioxidant genes contributes to redox-sensitive vascular dysfunction in hypertension. Hypertension 2015 66 1240 1250. doi: 10.1161/HYPERTENSIONAHA.115.06163
95. McSweeney SR, Warabi E, Siow RCM, Nrf2 as an endothelial mechanosensitive transcription factor going with the flow. Hypertension 2016 67 20 29
96. Chan CK, Liao SY, Zhang YL, Xu A, Tse HF, Vanhoutte PM, Protective effects of histamine on Gq-mediated relaxation in regenerated endothelium. Am J Physiol Heart Circ Physiol 2014 306 H286 H290. doi: 10.1152/ajpheart.00733.2013
97. Getz GS, Reardon CA, Arginine/arginase NO NO NO. Arterioscler Thromb Vasc Biol 2006 26 237 239. doi: 10.1161/01.ATV.0000202014.54609.9d
98. Böger RH, Bode-Böger SM, The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001 41 79 99. doi: 10.1146/annurev.pharmtox.41.1.79
99. Wilson AM, Harada R, Nair N, Balasubramanian N, Cooke JP, L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation 2007 116 188 195. doi: 10.1161/CIRCULATIONAHA.106.683656
100. Morris SM Jr, Enzymes of arginine metabolism. J Nutr 2004 134 2743S 2747S; discussion 2765S
101. Brandes RP, Roads to dysfunction: argininase II contributes to oxidized low-density lipoprotein-induced attenuation of endothelial NO production. Circ Res 2006 99 918 920. doi: 10.1161/01.RES.0000249617.15456.4c
102. Durante W, Johnson FK, Johnson RA, Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007 34 906 911. doi: 10.1111/j.1440-1681.2007.04638.x
103. Katusic ZS, Mechanisms of endothelial dysfunction induced by aging-role of arginase I. Circ Res 2007 101 640 641
104. Vanhoutte PM, Arginine and arginase: endothelial NO synthase double crossed? Circ Res 2008 102 866 868. doi: 10.1161/CIRCRESAHA.108.175570
105. Pernow J, Jung C, Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 2013 98 334 343. doi: 10.1093/cvr/cvt036
106. Pandey D, Bhunia A, Oh YJ, Chang F, Bergman Y, Kim JH, Serbo J, Boronina TN, Cole RN, Van Eyk J, Remaley AT, Berkowitz DE, Romer LH, OxLDL triggers retrograde translocation of arginase2 in aortic endothelial cells via ROCK and mitochondrial processing peptidase. Circ Res 2014 115 450 459. doi: 10.1161/CIRCRESAHA.115.304262
107. Hwang HM, Lee JH, Min BS, Jeon BH, Hoe KL, Kim YM, Ryoo S, A novel arginase inhibitor derived from Scutellavia indica restored endothelial function in apoe-null mice fed a high-cholesterol diet. J Pharmacol Exp Ther 2015 355 57 65. doi: 10.1124/jpet.115.224592
108. Kovamees O, Shemyakin A, Eriksson M, Angelin B, Pernow J, Arginase inhibition improves endothelial function in patients with familial hypercholesterolaemia irrespective of their cholesterol levels. J Intern Med 2016 279 477 484. doi: 10.1111/joim.12461
109. Shatanawi A, Lemtalsi T, Yao L, Patel C, Caldwell RB, Caldwell RW, Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway. Eur J Pharmacol 2015 746 106 114. doi: 10.1016/j.ejphar.2014.10.042
110. Gunnett CA, Lund DD, McDowell AK, Faraci FM, Heistad DD, Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler Thromb Vasc Biol 2005 25 1617 1622. doi: 10.1161/01.ATV.0000172626.00296.ba
111. Lin JY, Moens AL, Tetrahydrobiopterin and hypertension: more than an emigrating story. Am J Physiol Heart Circ Physiol 2011 300 H715. doi: 10.1152/ajpheart.01295.2010
112. Santhanam AV, d'Uscio LV, Katusic ZS, Erythropoietin increases bioavailability of tetrahydrobiopterin and protects cerebral microvasculature against oxidative stress induced by eNOS uncoupling. J Neurochem 2014 131 521 529. doi: 10.1111/jnc.12824
113. Zhang Z, Wang M, Xue SJ, Liu DH, Tang YB, Simvastatin ameliorates angiotensin II-induced endothelial dysfunction through restoration of Rho-BH4-eNOS-NO pathway. Cardiovasc Drugs Ther 2012 26 31 40. doi: 10.1007/s10557-011-6351-3
114. Mitchell BM, Dorrance AM, Mack EA, Webb RC, Glucocorticoids decrease GTP cyclohydrolase and tetrahydrobiopterin-dependent vasorelaxation through glucocorticoid receptors. J Cardiovasc Pharmacol 2004 43 8 13
115. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, Blaschke TF, Cooke JP, Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998 98 1842 1847
116. Vallance P, Leiper J, Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler Thromb Vasc Biol 2004 24 1023 1030. doi: 10.1161/01.ATV.0000128897.54893.26
117. Palm F, Onozato ML, Luo Z, Wilcox CS, Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 2007 293 H3227 H3245. doi: 10.1152/ajpheart.00998.2007
118. Sibal L, Agarwal SC, Home PD, Boger RH, The role of asymmetric dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev 2010 6 82 90. doi: 10.2174/157340310791162659
119. Antoniades C, Demosthenous M, Tousoulis D, Antonopoulos AS, Vlachopoulos C, Toutouza M, Marinou K, Bakogiannis C, Mavragani K, Lazaros G, Koumallos N, Triantafyllou C, Lymperiadis D, Koutsilieris M, Stefanadis C, Role of asymmetrical dimethylarginine in inflammation-induced endothelial dysfunction in human atherosclerosis. Hypertension 2011 58 93 98. doi: 10.1161/HYPERTENSIONAHA.110.168245
120. Wilcox CS, Asymmetric dimethylarginine and reactive oxygen species unwelcome twin visitors to the cardiovascular and kidney disease tables. Hypertension 2012 59 375 381
121. Ahmetaj-Shala B, Kirkby NS, Knowles R, Al'Yamani M, Mazi S, Wang Z, Tucker AT, Mackenzie L, Armstrong PC, Nüsing RM, Tomlinson JA, Warner TD, Leiper J, Mitchell JA, Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs. Circulation 2015 131 633 642. doi: 10.1161/CIRCULATIONAHA.114.011591
122. Rafikov R, Fonseca FV, Kumar S, Pardo D, Darragh C, Elms S, Fulton D, Black SM, eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J Endocrinol 2011 210 271 284. doi: 10.1530/JOE-11-0083
123. Chen CA, Wang TY, Varadharaj S, Reyes LA, Hemann C, Talukder MA, Chen YR, Druhan LJ, Zweier JL, S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010 468 1115 1118. doi: 10.1038/nature09599
124. Dulce RA, Schulman IH, Hare JM, S-glutathionylation: a redox-sensitive switch participating in nitroso-redox balance. Circ Res 2011 108 531 533. doi: 10.1161/RES.0b013e3182147d74
125. Speer T, Owala FO, Holy EW, Carbamylated low-density lipoprotein induces endothelial dysfunction. Eur Heart J 2014 35 3021 3032. doi: 10.1093/eurheartj/ehu111
126. Kim JA, Jang HJ, Hwang DH, Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of insulin. Am J Physiol Endocrinol Metab 2015 309 E767 E776. doi: 10.1152/ajpendo.00369.2015
127. Bretón-Romero R, Feng B, Holbrook M, Farb MG, Fetterman JL, Linder EA, Berk BD, Masaki N, Weisbrod RM, Inagaki E, Gokce N, Fuster JJ, Walsh K, Hamburg NM, endothelial dysfunction in human diabetes is mediated by Wnt5a-JNK Signaling. Arterioscler Thromb Vasc Biol 2016 36 561 569. doi: 10.1161/ATVBAHA.115.306578
128. Javaheri A, Rader DJ, High-density lipoprotein no failure in heart failure. Circ Res 2013 113 1275 1277
129. Tran-Dinh A, Diallo D, Delbosc S, Varela-Perez LM, Dang QB, Lapergue B, Burillo E, Michel JB, Levoye A, Martin-Ventura JL, Meilhac O, HDL and endothelial protection. Br J Pharmacol 2013 169 493 511. doi: 10.1111/bph.12174
130. Lüscher TF, Landmesser U, von Eckardstein A, Fogelman AM, High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res 2014 114 171 182. doi: 10.1161/CIRCRESAHA.114.300935
131. Sun JT, Yang K, Lu L, Zhu ZB, Zhu JZ, Ni JW, Han H, Chen N, Zhang RY, Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function. Am J Physiol Renal Physiol 2016 310 F511 F517. doi: 10.1152/ajprenal.00508.2015
132. Carlström M, Liu M, Yang T, Zollbrecht C, Huang L, Peleli M, Borniquel S, Kishikawa H, Hezel M, Persson AE, Weitzberg E, Lundberg JO, Cross-talk between nitrate-nitrite-NO and NO synthase pathways in control of vascular NO homeostasis. Antioxid Redox Signal 2015 23 295 306. doi: 10.1089/ars.2013.5481
133. Carrizzo A, Lenzi P, Procaccini C, Pentraxin 3 induces vascular endothelial dysfunction through a P-selectin/matrix metalloproteinase-1 pathway. Circulation 2015 131 1495 1505; discussion 1505. doi: 10.1161/CIRCULATIONAHA.114.014822
134. Loirand G, Pacaud P, Involvement of Rho GTPases and their regulators in the pathogenesis of hypertension. Small GTPases 2014 5 1 10. doi: 10.4161/sgtp.28846
135. Stanley CP, Hind WH, Tufarelli C, O'Sullivan SE, Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovasc Res 2015 107 568 578. doi: 10.1093/cvr/cvv179
136. Yar S, Chang HC, Ardehali H, The good neighbor: coping with insulin resistance by modulating adipose tissue endothelial cell function. Circ Res 2016 118 776 778. doi: 10.1161/CIRCRESAHA.116.308338
137. Cho DH, Choi YJ, Jo SA, Jo I, Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone: evidence for involvement of peroxisome proliferator-activated receptor (PPAR) gamma-dependent and PPARgamma-independent signaling pathways. J Biol Chem 2004 279 2499 2506. doi: 10.1074/jbc.M309451200
138. Solini A, Rossi C, Duranti E, Taddei S, Natali A, Virdis A, Saxagliptin prevents vascular remodeling and oxidative stress in db/db mice. Role of endothelial nitric oxide synthase uncoupling and cyclooxygenase. Vascul Pharmacol 2016 76 62 71. doi: 10.1016/j.vph.2015.10.002
139. Davis BJ, Xie Z, Viollet B, Zou MH, Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006 55 496 505
140. Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H, Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Am J Hypertens 2008 21 576 581. doi: 10.1038/ajh.2008.27
141. Gupta S, Wright HM, Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. Cardiovasc Ther 2008 26 189 202. doi: 10.1111/j.1755-5922.2008.00054.x
142. Yuen CY, Wong WT, Tian XY, Wong SL, Lau CW, Yu J, Tomlinson B, Yao X, Huang Y, Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase. Cardiovasc Res 2011 90 122 129. doi: 10.1093/cvr/cvq392
143. Datar R, Kaesemeyer WH, Chandra S, Fulton DJ, Caldwell RW, Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx. Br J Pharmacol 2010 160 1765 1772. doi: 10.1111/j.1476-5381.2010.00817.x
144. Goya K, Sumitani S, Xu X, Kitamura T, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S, Kawase I, Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2004 24 658 663. doi: 10.1161/01.ATV.0000118682.58708.78
145. Gong X, Ma Y, Ruan Y, Fu G, Wu S, Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta. Exp Gerontol 2014 52 9 17. doi: 10.1016/j.exger.2014.01.015
146. Nohria A, Grunert ME, Rikitake Y, Noma K, Prsic A, Ganz P, Liao JK, Creager MA, Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease. Circ Res 2006 99 1426 1432. doi: 10.1161/01.RES.0000251668.39526.c7
147. Shimokawa H, Sunamura S, Satoh K, RhoA/Rho-kinase in the cardiovascular system. Circ Res 2016 118 352 366. doi: 10.1161/CIRCRESAHA.115.306532
148. Kojda G, Harrison D, Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 1999 43 562 571
149. Montezano AC, Touyz RM, Reactive oxygen species and endothelial function-role of nitric oxide synthase uncoupling and Nox family nicotinamide adenine dinucleotide phosphate oxidases. Basic Clin Pharmacol Toxicol 2012 110 87 94. doi: 10.1111/j.1742-7843.2011.00785.x
150. Pacher P, Beckman JS, Liaudet L, Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007 87 315 424. doi: 10.1152/physrev.00029.2006
151. Franco MC, Estévez AG, Tyrosine nitration as mediator of cell death. Cell Mol Life Sci 2014 71 3939 3950. doi: 10.1007/s00018-014-1662-8
152. Stuehr D, Pou S, Rosen GM, Oxygen reduction by nitric-oxide synthases. J Biol Chem 2001 276 14533 14536. doi: 10.1074/jbc.R100011200
153. Xiong S, Wang P, Ma L, Gao P, Gong L, Li L, Li Q, Sun F, Zhou X, He H, Chen J, Yan Z, Liu D, Zhu Z, ameliorating endothelial mitochondrial dysfunction restores coronary function via transient receptor potential vanilloid 1-mediated protein kinase A/uncoupling protein 2 pathway. Hypertension 2016 67 451 460. doi: 10.1161/HYPERTENSIONAHA.115.06223
154. Feng W, Ying WZ, Aaron KJ, Sanders PW, Transforming growth factor-β mediates endothelial dysfunction in rats during high salt intake. Am J Physiol Renal Physiol 2015 309 F1018 F1025. doi: 10.1152/ajprenal.00328.2015
155. McCarthy CG, Wenceslau CF, Goulopoulou S, Ogbi S, Baban B, Sullivan JC, Matsumoto T, Webb RC, Circulating mitochondrial DNA and Toll-like receptor 9 are associated with vascular dysfunction in spontaneously hypertensive rats. Cardiovasc Res 2015 107 119 130. doi: 10.1093/cvr/cvv137
156. Beyer AM, Freed JK, Durand MJ, Riedel M, Ait-Aissa K, Green P, Hockenberry JC, Morgan RG, Donato AJ, Peleg R, Gasparri M, Rokkas CK, Santos JH, Priel E, Gutterman DD, Critical role for telomerase in the mechanism of flow-mediated dilation in the human microcirculation. Circ Res 2016 118 856 866. doi: 10.1161/CIRCRESAHA.115.307918
157. Lorenz M, Klinkner L, Baumann G, Stangl K, Stangl V, Endothelial NO Production Is Mandatory for Epigallocatechin-3-Gallate-induced Vasodilation: Results From eNOS Knockout (eNOS-/-) Mice. J Cardiovasc Pharmacol 2015 65 607 610. doi: 10.1097/FJC.0000000000000232
158. Virdis A, Duranti E, Colucci R, Ippolito C, Tirotta E, Lorenzini G, Bernardini N, Blandizzi C, Taddei S, Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase. Eur Heart J 2015 36 3023 3030. doi: 10.1093/eurheartj/ehv365
159. Klöss S, Bouloumié A, Mülsch A, Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension 2000 35 43 47
160. Kim D, Rybalkin SD, Pi X, Wang Y, Zhang C, Munzel T, Beavo JA, Berk BC, Yan C, Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance. Circulation 2001 104 2338 2343
161. Xu X, Wang S, Liu J, Dou D, Liu L, Chen Z, Ye L, Liu H, He Q, Raj JU, Gao Y, Hypoxia induces downregulation of soluble guanylyl cyclase β1 by miR-34c-5p. J Cell Sci 2012 125 6117 6126. doi: 10.1242/jcs.113381
162. Zheng X, Ying L, Liu J, Dou D, He Q, Leung SW, Man RY, Vanhoutte PM, Gao Y, Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide. Cardiovasc Res 2011 90 565 572. doi: 10.1093/cvr/cvr016
163. Dou D, Zheng X, Ying L, Ye L, Gao Y, Sulfhydryl-dependent dimerization and cGMP-mediated vasodilatation. J Cardiovasc Pharmacol 2013 62 1 5. doi: 10.1097/FJC.0b013e3182813865
164. Heckler EJ, Crassous PA, Baskaran P, Beuve A, Protein disulfide-isomerase interacts with soluble guanylyl cyclase via a redox-based mechanism and modulates its activity. Biochem J 2013 452 161 169. doi: 10.1042/BJ20130298
165. Sayed N, Baskaran P, Ma X, van den Akker F, Beuve A, Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 2007 104 12312 12317. doi: 10.1073/pnas.0703944104
166. Kumar V, Martin F, Hahn MG, Schaefer M, Stamler JS, Stasch JP, van den Akker F, Insights into BAY 60-2770 activation and S-nitrosylation-dependent desensitization of soluble guanylyl cyclase via crystal structures of homologous nostoc H-NOX domain complexes. Biochemistry 2013 52 3601 3608. doi: 10.1021/bi301657w
167. Jones AW, Durante W, Korthuis RJ, Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation. J Pharmacol Exp Ther 2010 335 85 91. doi: 10.1124/jpet.110.169755
168. Bautista Niño PK, Durik M, Danser AH, Phosphodiesterase 1 regulation is a key mechanism in vascular aging. Clin Sci (Lond) 2015 129 1061 1075. doi: 10.1042/CS20140753
169. Dou D, Zheng X, Qin X, Qi H, Liu L, Raj JU, Gao Y, Role of cGMP-dependent protein kinase in development of tolerance to nitroglycerine in porcine coronary arteries. Br J Pharmacol 2008 153 497 507. doi: 10.1038/sj.bjp.0707600
170. Chettimada S, Rawat DK, Dey N, Kobelja R, Simms Z, Wolin MS, Lincoln TM, Gupte SA, Glc-6-PD and PKG contribute to hypoxia-induced decrease in smooth muscle cell contractile phenotype proteins in pulmonary artery. Am J Physiol Lung Cell Mol Physiol 2012 303 L64 L74. doi: 10.1152/ajplung.00002.2012
171. Hu XQ, Zhang L, Function and regulation of large conductance Ca(2+)-activated K+ channel in vascular smooth muscle cells. Drug Discov Today 2012 17 974 987. doi: 10.1016/j.drudis.2012.04.002
172. Joseph BK, Thakali KM, Moore CL, Rhee SW, Ion channel remodeling in vascular smooth muscle during hypertension: Implications for novel therapeutic approaches. Pharmacol Res 2013 70 126 138. doi: 10.1016/j.phrs.2013.01.008
173. Yang Y, Li PY, Cheng J, Mao L, Wen J, Tan XQ, Liu ZF, Zeng XR, Function of BKCa channels is reduced in human vascular smooth muscle cells from Han Chinese patients with hypertension. Hypertension 2013 61 519 525. doi: 10.1161/HYPERTENSIONAHA.111.00211
174. Gao Y, Chen Z, Leung SW, Vanhoutte PM, Hypoxic vasospasm mediated by cIMP: when soluble guanylyl cyclase turns bad. J Cardiovasc Pharmacol 2015 65 545 548. doi: 10.1097/FJC.0000000000000167
175. Beste KY, Seifert R, cCMP, cUMP, cTMP, cIMP and cXMP as possible second messengers: development of a hypothesis based on studies with soluble guanylyl cyclase α(1)β(1). Biol Chem 2013 394 261 270. doi: 10.1515/hsz-2012-0282
176. Detremmerie CM, Leung SWS, Xu A, Gao Y, Vanhoutte PM, Biased activation of soluble guanylyl cyclase can cause contraction of isolated arteries. FASEB J 2016 719 11
177. Gao Y, Vanhoutte PM, Tissues cIMPly do not lie. Naunyn Schmiedebergs Arch Pharmacol 2014 387 901 903. doi: 10.1007/s00210-014-1022-0
178. Vanhoutte PM, Endothelial Lessons. Curr Vasc Pharmacol 2016 14 175 180
179. Kovacevic I, Müller M, Kojonazarov B, Ehrke A, Randriamboavonjy V, Kohlstedt K, Hindemith T, Schermuly RT, Fleming I, Hoffmeister M, Oess S, The F-BAR Protein NOSTRIN dictates the localization of the muscarinic M3 receptor and regulates cardiovascular function. Circ Res 2015 117 460 469. doi: 10.1161/CIRCRESAHA.115.306187
180. Feng J, Damrauer SM, Lee M, Sellke FW, Ferran C, Abid MR, Endothelium-dependent coronary vasodilatation requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol 2010 30 1703 1710. doi: 10.1161/ATVBAHA.110.209726
181. Anselm E, Chataigneau M, Ndiaye M, Chataigneau T, Schini-Kerth VB, Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src-and Akt-dependent activation of eNOS. Cardiovasc Res 2007 73 404 413. doi: 10.1016/j.cardiores.2006.08.004
182. Rowlands DJ, Chapple S, Siow RCM, Mann GE, Equol-stimulated mitochondrial reactive oxygen species activate endothelial nitric oxide synthase and redox signaling in endothelial cells roles for F-actin and GPR30. Hypertension 2011 57 833 840
183. Bubolz AH, Mendoza SA, Zheng X, Zinkevich NS, Li R, Gutterman DD, Zhang DX, Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca2+ entry and mitochondrial ROS signaling. Am J Physiol Heart Circ Physiol 2012 302 H634 H642. doi: 10.1152/ajpheart.00717.2011
184. Sanchez-Gomez FJ, Calvo E, Breton-Romero R, Fierro-Fernandez M, Anilkumar N, Shah AM, Schroder K, Brandes RP, Vazquez J, Lamas S, NOX4-dependent hydrogen peroxide promotes shear stress-induced SHP2 sulfenylation and eNOS activation. Free Radic Biol Med 2015 89 419 430
185. Rocha JT, Hipólito UV, Callera GE, Yogi A, Neto Filho Mdos A, Bendhack LM, Touyz RM, Tirapelli CR, Ethanol induces vascular relaxation via redox-sensitive and nitric oxide-dependent pathways. Vascul Pharmacol 2012 56 74 83. doi: 10.1016/j.vph.2011.11.006
186. Duffy SJ, Gokce N, Holbrook M, Hunter LM, Biegelsen ES, Huang A, Keaney JF Jr, Vita JA, Effect of ascorbic acid treatment on conduit vessel endothelial dysfunction in patients with hypertension. Am J Physiol Heart Circ Physiol 2001 280 H528 H534
187. Pellegrini MP, Newby DE, Johnston NR, Maxwell S, Webb DJ, Vitamin C has no effect on endothelium-dependent vasomotion and acute endogenous fibrinolysis in healthy smokers. J Cardiovasc Pharmacol 2004 44 117 124
188. Moat SJ, Madhavan A, Taylor SY, Payne N, Allen RH, Stabler SP, Goodfellow J, McDowell IF, Lewis MJ, Lang D, High-but not low-dose folic acid improves endothelial function in coronary artery disease. Eur J Clin Invest 2006 36 850 859. doi: 10.1111/j.1365-2362.2006.01739.x
189. Strålin P, Karlsson K, Johansson BO, Marklund SL, The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995 15 2032 2036